Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Gordon

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonusM F Gordon, R I Abrams, D B Rubin, et al.
Neurology|December 1, 1994
Bismuth toxicityM F Gordon, R I Abrams, D B Rubin, et al.
Neurology|November 24, 2004
Repeated dosing of botulinum toxin type A for upper limb spasticity following strokeM F Gordon, A Brashear, E Elovic, et al.
European Journal of Clinical Pharmacology|September 7, 2021
The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteersF Schneider, D Stamler, M J Bradbury, et al.
The Journal of Clinical Psychiatry|September 1, 1994
The use of clozapine in neurologic disordersA Z Safferman, J M Kane, J S Aronowitz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
Case 2, 1994: parkinsonism and cognitive impairmentM F Gordon, W J Weiner, W C Koller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Dystonia in a patient with deletion of 18qM F Gordon, S Bressman, M F Brin, et al.
Neurology|February 20, 1999
Genetic analysis of three patients with an 18p- syndrome and dystoniaC Klein, C E Page, P LeWitt, et al.
Neurology|February 1, 1994
A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneityS B Bressman, G A Heiman, T G Nygaard, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonusM F Gordon, R I Abrams, D B Rubin, et al.
Neurology|December 1, 1994
Bismuth toxicityM F Gordon, R I Abrams, D B Rubin, et al.
Neurology|November 24, 2004
Repeated dosing of botulinum toxin type A for upper limb spasticity following strokeM F Gordon, A Brashear, E Elovic, et al.
European Journal of Clinical Pharmacology|September 7, 2021
The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteersF Schneider, D Stamler, M J Bradbury, et al.
The Journal of Clinical Psychiatry|September 1, 1994
The use of clozapine in neurologic disordersA Z Safferman, J M Kane, J S Aronowitz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
Case 2, 1994: parkinsonism and cognitive impairmentM F Gordon, W J Weiner, W C Koller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Dystonia in a patient with deletion of 18qM F Gordon, S Bressman, M F Brin, et al.
Neurology|February 20, 1999
Genetic analysis of three patients with an 18p- syndrome and dystoniaC Klein, C E Page, P LeWitt, et al.
Neurology|February 1, 1994
A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneityS B Bressman, G A Heiman, T G Nygaard, et al.
Pageof 2